These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7263929)

  • 1. The assessment of the intrasubject variability in digoxin absorption in man from two oral dosage forms.
    Yacobi A; Stoll RG; Chao GC; Schwartz RA; Weidler DJ; Ayers JW; Sakmar E; Hallmark M; Wagner JG
    J Clin Pharmacol; 1981 Jul; 21(7):301-10. PubMed ID: 7263929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A completely absorbed oral preparation of digoxin.
    Johnson BF; Bye C; Jones G; Sabey GA
    Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Greater bioavailability of digoxin solution in capsules. Studies in the postprandial state.
    Lindenbaum J
    Clin Pharmacol Ther; 1977 Mar; 21(3):278-82. PubMed ID: 576419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superior bioavailability of digoxin solution in capsules.
    Mallis GI; Schmidt DH; Lindenbaum J
    Clin Pharmacol Ther; 1975 Dec; 18(6):761-8. PubMed ID: 1106935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin.
    Alvisi V; Longhini C; Bagni B; Portaluppi F; Ruina M; Fersini C
    Arzneimittelforschung; 1979; 29(7):1047-50. PubMed ID: 582997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability of digoxin capsules and tablets: effect of coadministered fluid volume.
    Bustrack JA; Katz JD; Hull JH; Foster JR; Hammond JE; Christenson RH
    J Pharm Sci; 1984 Oct; 73(10):1397-400. PubMed ID: 6502488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF; Smith G; French J
    Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
    Bjornsson TD; Huang AT; Roth P; Jacob DS; Christenson R
    Clin Pharmacol Ther; 1986 Jan; 39(1):25-8. PubMed ID: 3943266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intersubject variation in absorption of digoxin in normal volunteers.
    Huffman DH; Manion CV; Azarnoff DL
    J Pharm Sci; 1975 Mar; 64(3):433-7. PubMed ID: 1151628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients.
    Astorri E; Bianchi G; La Canna G; Assanelli D; Visioli O; Marzo A
    J Pharm Sci; 1979 Jan; 68(1):104-6. PubMed ID: 364006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.
    Brown DD; Schmid J; Long RA; Hull JH
    J Clin Pharmacol; 1985; 25(5):360-4. PubMed ID: 4031112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting and postprandial absorption of digoxin from a microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1983; 25(2):207-10. PubMed ID: 6628502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose bioavailability of two different digoxin tablets.
    Jonkman JH; Gusdorf CF; van der Boon WJ; Grasmeijer G; Jedema JN
    Arzneimittelforschung; 1987 Jan; 37(1):62-5. PubMed ID: 3566859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of magnesium--aluminum hydroxide and kaolin--pectin on absorption of digoxin from tablets and capsules.
    Allen MD; Greenblatt DJ; Harmatz JS; Smith TW
    J Clin Pharmacol; 1981 Jan; 21(1):26-30. PubMed ID: 7012189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metoclopramide on digoxin absorption from tablets and capsules.
    Johnson BF; Bustrack JA; Urbach DR; Hull JH; Marwaha R
    Clin Pharmacol Ther; 1984 Dec; 36(6):724-30. PubMed ID: 6499354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal intestinal absorption of digoxin, and its relation to steady state plasma concentration.
    Johnson BF; Bye C
    Br Heart J; 1975 Feb; 37(2):203-8. PubMed ID: 1091283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.